Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Introduction to Epidemiology01:26

Introduction to Epidemiology

742
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
742
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacovigilance01:19

Pharmacovigilance

850
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

476
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
476

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

European journal of clinical pharmacology·2024
Same author

The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study).

Journal of clinical medicine·2023
Same author

Medical Students' Opinion of Their Learning Process.

Medical science educator·2023
Same author

Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital.

Journal of clinical medicine·2021
Same author

Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study.

Journal of clinical medicine·2021
Same author

Epidemiology of drug-related deaths in European hospitals: A systematic review and meta-analysis of observational studies.

British journal of clinical pharmacology·2021

相关实验视频

Updated: Jul 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

药学流行病学:一个概述

Mònica Sabaté1,2, Eva Montané2,3

  • 1Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Clinical Pharmacology Research Group, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.

Journal of clinical medicine
|November 25, 2023
PubMed
概括

药理流行病学对于了解临床试验以外的现实药物安全性和有效性至关重要. 本综述涵盖了其方法,趋势以及现实世界的证据在医疗保健和政策中的作用.

关键词:
药物不良反应 药物不良反应药物安全 药物安全有效性 有效性.患者安全 患者安全药学流行病学 药学流行病学药物监督和药物监督监管决定 监管决定

更多相关视频

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

834

相关实验视频

Last Updated: Jul 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

834

科学领域:

  • 药学流行病学 药学流行病学
  • 现实世界的证据.
  • 药物安全和有效性 药物安全和有效性

背景情况:

  • 随机临床试验 (RCT) 在反映现实药物结果方面存在局限性.
  • 医疗保健专业人员和监管机构需要关于大群体中药物安全性和有效性的可靠数据.
  • 药物流行病学研究对于为基于证据的医学和公共卫生政策提供信息至关重要.

研究的目的:

  • 为药理流行病学提供全面的概述,包括其定义,范围和方法.
  • 讨论未来的趋势,偏见和混的新方法,以及将现实世界的证据整合到药物开发中.
  • 为从事制药流行病学研究的临床医生提供建议.

主要方法:

  • 对药物流行病学研究设计和方法的审查.
  • 讨论新兴趋势和先进的偏见和混缓解技术.
  • 在现实世界数据管理中探索人工智能应用.

主要成果:

  • 强调需要制药流行病学研究来进行现实世界药物评估.
  • 概述了进行和解释药物流行病学研究的关键方面.
  • 报告新方法和倡议,以产生有效的现实世界的证据.

结论:

  • 药理流行病学弥合了临床试验数据和现实世界药物性能之间的差距.
  • 该领域正在随着新方法和人工智能的整合而发展.
  • 本综述为研究人员和临床医生在药物流行病学研究中的指南.